A review of BB Biotech’s portfolio and results for 2024 as well as the outlook for 2025 will be included in the Annual Report, to be published on February 21, 2025. The figures and information ...
As part of the offering, the Purchasers were also issued an aggregate of 1,526,058 shares of the Company's common stock, par value $0.0001 per share. Alternus has agreed to file a registration ...